NSE · SANGINITA
Sanginita Chemicals Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹25 Cr with net profit ₹-11 Cr — a -45.12% net margin, versus -5.48% the period before.
Shareholding
As of 2026-06-30
- Promoter68%
- Public32%
12,739 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 8.14× from low to high.
Risk flags
Derived from disclosed data
- Under exchange surveillance — ESM · ESM 2 · T2T. Trading may carry price bands, periodic call auction or higher margins.
- 52-week range spans 8.14× (₹9.26 to ₹75.39) — an unusually wide band.
Peer comparison
Chemicals · ranked #85 of 161 by market cap · medians across 50 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Solar Industries India Ltd. | ₹1,78,537 Cr | 89.65 | 28.43 | 26.72% | 17.54% |
| Pidilite Industries Ltd. | ₹1,61,754 Cr | 61.08 | 14.91 | 22.61% | 17.2% |
| SRF Ltd. | ₹75,588 Cr | 33.73 | 5.36 | 13.07% | 13.01% |
| Linde India Limited | ₹53,610 Cr | 98.11 | 12.57 | 12.87% | 20.59% |
| Gujarat Fluorochemicals Ltd. | ₹49,173 Cr | 79.61 | 6.28 | 7.13% | 11.41% |
| Navin Fluorine International Ltd. | ₹43,399 Cr | 54.57 | 10.91 | 16.69% | 21.73% |
| Godrej Industries Ltd. | ₹37,256 Cr | 30.45 | 3.33 | 11.1% | 5.06% |
| Himadri Speciality Chem Limited | ₹33,693 Cr | 42.16 | 7.16 | 15.96% | 16.07% |
| Deepak Nitrite Ltd. | ₹22,311 Cr | 28.16 | 3.82 | 9.43% | 9.13% |
| Aether Industries Limited | ₹21,876 Cr | 91.16 | 8.92 | 8.94% | 19.11% |
| Sanginita Chemicals Ltd.(this company) | ₹455 Cr | 37.46 | 5.7 | — | -15.49% |
AI analysis
AI-generated · google/gemini-2.5-flashSanginita Chemicals Ltd. is listed on the Indian markets with a market capitalization of Rs 148 Cr. The company reported revenue of Rs 229.94 Cr and a profit margin of -5.49%. Its 52-week high was Rs 56.96 and its 52-week low was Rs 9.09.
Positives
- +Promoter shareholding is substantial at 67.9804%.
- +The debt-to-equity ratio is 0.61, indicating moderate leverage.
- +No promoter shares are pledged, with a promoter pledge percentage of 0%.
Negatives
- −The company's profit margin is negative at -5.49%.
- −Return on equity is negative at -20.85%.
- −Return on Capital Employed (ROCE) is negative at -13.2888%.
- −Quarterly revenue has declined from Rs 61.54 Cr in Dec 2024 to Rs 42.97 Cr in Mar 2026.
- −The company is under ESM Stage 2 surveillance.
Financial performance
Sanginita Chemicals Ltd. reported revenue of Rs 229.94 Cr. The company's net profit for the year ending Mar 2025 was Rs 0.6185 Cr, following a net profit of Rs 0.7698 Cr in Mar 2024. Quarterly revenue has shown a declining trend recently, from Rs 61.54 Cr in Dec 2024 to Rs 42.97 Cr in Mar 2026.
Profitability & returns
The company's profit margin stands at -5.49%. Return on equity (ROE) is -20.85% and Return on Capital Employed (ROCE) is -13.2888%. Earnings per share (EPS) for the latest available annual data is 0.24 for Mar 2025. Quarterly EPS figures are not available.
Balance sheet
Sanginita Chemicals Ltd. has a debt-to-equity ratio of 0.61. The book value per share is Rs 17.94. There are no pledges reported by the promoters.
Ownership & pledges
Public shareholding stands at 32.0196%. There is no FII or DII holding and no institutional holding reported. No promoter shareholding is pledged.
Regulatory & surveillance
The company is currently under ESM Stage 2 surveillance ('ESM · ESM 2'). This indicates specific monitoring measures are in place for the stock.
Data as of — price: 2026-09-24 · financials: Jun 26 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.